Enzymes
Enzymes(酶)
Enzymes are very efficient and specific catalyst proteins which react with 1 or few types of substrates in biochemical reactions and are responsible for bringing about almost all of the chemical reactions in living organisms. Enzymes speed up reactions by providing an alternative reaction pathway of lower activation energy. Without enzymes, reactions take place at a rate far too slow for the pace of metabolism which means that they speed up the chemical reactions in living things.
There are 2 types of enzymes, ones that help join specific molecules together to form new molecules & others that help break specific molecules apart into separate molecules. Enzymes play many important roles ouside the cell as well. One of the best examples of this is the digestive system. For instance, it is enzymes in your digestive system that break food down in your digestive system break food down into small molecules that can be absorbed by the body. Some enzymes in your digestive system break down starch, some proteins and others break down fats. The enzymes used to digest our food are extra-cellular since they are located outside our cells & enzymes inside our cells are intra-cellular enzymes. Enzymes are used in ALL chemical reactions in living things; this includes respiration, photosynthesis, movement growth, getting rid of toxic chemicals in the liver and so on. Enzymes are proteins that must have the correct structure to be active. They are very easily affected by heat, pH and heavy metal ions.
Ribonucleoprotein enzyme catalytic activity is located in the protein part but for some the catalytic activity is in the RNA part. A catalyst is any substance which makes a chemical reaction go faster, without itself being changed. A catalyst can be used over and over again in a chemical reaction and does not get used up.
Enzymes lower the amount of activation energy needed by binding to the reactants of the reaction they catalyze, thus speed up the reaction and can process millions of molecules per second. Enzymes are typically large proteins with high molecular weight that permit reactions to go at conditions that the body can tolerate.
Enzyme nomenclature is based on what the enzyme reacts with & how it reacts along with the ending ase.
Enzymes must get over the activation energy hurdle.
Enzymes change how a reaction will proceed which reduces the activation energy and makes it faster. The more we increase the enzyme concentration the faster the reaction rate for non-catalyzed reactions. Enzymes that are catalyzed reactions also increase reaction rate at higher level of concentration but up to a certain point called Vmax which means that the enzyme has reached its maximum point. The reaction is limited by both the concentrations of the enzyme and substrate. Enzymes as catalysts take part in reactions which provide an alternative reaction pathway. Enzymes do not undergo permanent changes and remain unchanged at the end of the reaction. They only change the rate of reaction, not the position of the equilibrium.Enzymes as catalysts are highly selective by only catalysing specific reactions due to the shapes of the enzyme’s molecule.
Enzymes contain a globular protein part called apoenzyme and a non-protein part named cofactor or prosthetic group or metal-ion-activator. Changes in temperature and pH have great influence on the intra- and intermolecular bonds that hold the protein part in their secondary and tertiary structures.
Examples of cofactors are 1. Prosthetic group that are permanently bound to the enzyme. 2. Activator group which are cations (positively charged metal ions) & temporarily bind to the active site of the enzyme. 3.Coenzymes, usually vitamins or made from vitamins which are not permanently bound to the enzyme molecule, but combine with the enzyme-substrate complex temporarily. Enzymes require the presence cofactors before their catalytic activity can be exerted. This entire active complex is referred to as the holoenzyme.
Without enzymes, our guts would take weeks to digest our food, our muscles, nerves and bones would not work properly and so on…
Main Enzyme category groups:
Oxidoreductases:
All enzymes that catalyse oxido-reductions belong in this class. The substrate oxidized is regarded as a hydrogen or electron donor. The classification is based on 'donor:acceptor oxidoreductase'. The common name is 'dehydrogenase', wherever this is possible; as an alternative, 'acceptor reductase' can be used. 'Oxidase' is used only where O2 is an acceptor. Classification is difficult in some cases, because of the lack of specificity towards the acceptor.
Transferases:
Transferases are enzymes that transfer a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme 'donor:acceptor grouptransferase'. The common names are normally formed as 'acceptor grouptransferase' or 'donor grouptransferase'. In many cases, the donor is a cofactor (coenzyme) that carries the group to be transferred. The aminotransferases constitute a special case.
Hydrolases:
These enzymes catalyse the hydrolysis of various bonds. Some of these enzymes pose problems because they have a very wide specificity, and it is not easy to decide if two preparations described by different authors are the same, or if they should be listed under different entries. While the systematic name always includes 'hydrolase', the common name is, in most cases, formed by the name of the substrate with the suffix -ase. It is understood that the name of the substrate with this suffix, and no other indicator, means a hydrolytic enzyme. It should be noted that peptidases have recommended names rather than common names.
Lyases:
Lyases are enzymes that cleave C-C, C-O, C-N and other bonds by means other than by hydrolysis or oxidation. They differ from other enzymes in that two (or more) substrates are involved in one reaction direction, but there is one compound fewer in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring. The systematic name is formed according to 'substrate group-lyase'. In common names, expressions like decarboxylase, aldolase, etc. are used. 'Dehydratase' is used for those enzymes that eliminate water. In cases where the reverse reaction is the more important, or the only one to be demonstrated, 'synthase' may be used in the name.
Ligases:
Ligases are enzymes that catalyse the joining of two molecules with concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. 'Ligase' is often used for the common name, but, in a few cases, 'synthase' or 'carboxylase' is used. 'Synthetase' may be used in place of 'synthase' for enzymes in this class.
- 41701(11)
- Activating Transcription Factor(3)
- Adenylate Kinase(10)
- AHCY(3)
- Aldolase(9)
- Asparaginase(5)
- Aurora Kinase(18)
- Beta Lactamase(3)
- Calcium and Integrin Binding(2)
- Calcium/Calmodulin-Dependent Protein Kinase(4)
- Carbonic Anhydrase(49)
- Casein Kinase(36)
- Cathepsin(52)
- Chitinase(5)
- Creatin Kinases(9)
- Cyclin(7)
- Cyclin-Dependent Kinase(18)
- Cyclophilin(23)
- Deaminase(14)
- Decarboxylase(12)
- Dehydrogenase(96)
- Discoidin Domain Receptor Tyrosine Kinase(2)
- DNA Polymerase(4)
- EGF Receptor(3)
- Endonuclease(6)
- Enolase(10)
- Enterokinase(5)
- Epimerase(3)
- Esterase(15)
- FGF Receptors(12)
- FK506 Binding Protein(10)
- Fructosamine 3 Kinase(2)
- Galactosidase(5)
- Glucosidase(32)
- Gluteradoxin(7)
- Glycogen synthase kinase(2)
- Glycosylase(10)
- Glyoxalase(3)
- Granzyme(7)
- Guanylate Kinase(2)
- Heparanase(3)
- Histone Deacetylase(3)
- Hydratase(10)
- Hydrolase(33)
- Hydroxylase(6)
- Isomerase(26)
- Jun N-terminal Kinase(1)
- Jun Proto-Oncogene(2)
- Kallikrein(26)
- Ligase(4)
- Lipase(14)
- Lipocalin(6)
- Lyase(9)
- LYVE1(3)
- Mitogen-Activated Protein Kinase(16)
- MMP(71)
- Mutase(11)
- Natural Enzymes(4)
- Nuclease(18)
- Nucleotidase(4)
- Nudix Type Motif(11)
- Other Enzymes(63)
- Oxidase(23)
- Oxygenase(12)
- Paraoxonase(3)
- Peptidase(41)
- Peroxiredoxin(10)
- Phosphatase(150)
- Phosphorylase(9)
- PI3-kinase(5)
- Polymerase(13)
- PPARG(2)
- Protease(15)
- Proteasome(55)
- Protein Kinase Akt1/PKB alpha(4)
- Protein Kinase-A(7)
- Protein Kinase-C(3)
- Protein Kinases(86)
- Protein Tyrosine Phosphatase(10)
- Reductase(60)
- Secreted Phospholipase A2(10)
- Serine Threonine Kinase(4)
- Sulfatase(8)
- Synthase(23)
- Synthetase(33)
- TGFBR(3)
- TGM2(3)
- TIE1,TIE2
- TIMP(10)
- TPA(4)
- ransaminase
- Transferase(156)
- Tyrosine Kinase(9)
- Ubiquitin Conjugating Enzyme(39)
- Uromodulin(4)
- VEGF Receptors(14)
- Transaminase(19)
- Hexokinase(6)
- TIE1(6)
Enzymes 相关产品(1726)
- GC64161Calcium glycerophosphateCAS: 27214-00-2纯度: >98.00%
Calcium glycerophosphate 是肠道碱性磷酸酶 F3 的抑制剂 (intestinal alkaline phosphatase F3)。Calcium glycerophosphate是全肠外营养溶液中钙和磷的来源。
- GC64202Ganoderlactone DCAS: 1801934-15-5纯度: >99.00%
Ganoderlactone D 对酵母中的α-葡萄糖苷酶有抑制活性,IC50 为 41.7 μM。
- GC64213GSK3494245CAS: 2080410-41-7纯度: >98.00%
GSK3494245 (DDD01305143) 是一种有效的、具有口服活性的、选择性的可在夹在 β4 和 β5 亚基之间的位点结合寄生虫蛋白酶体 (proteasome) 的糜蛋白酶样活性抑制剂(对于 WT L.donovani蛋白酶体IC50=0.16μM)。GSK3494245 适度抑制人蛋白酶体的糜蛋白酶样活性 (IC50: 26S=13 µM;富集的 THP-1 提取物 IC50=40 µM)。GSK3494245 具有良好的生物安全特性。
- GC6447220S Proteasome-IN-1CAS: 858557-69-4纯度: >99.00%
20S Proteasome-IN-1 是一种 26S proteasome 抑制剂,详细信息请参考专利文献 WO2006128196A2 中的化合物 2。20S Proteasome-IN-1 具有用于癌症,免疫相关疾病,炎症,缺血性疾病,神经退行性疾病和其他疾病研究的潜力。
- GC64519Kaempferol-3,7-di-O-β-glucosideCAS: 25615-14-9
Kaempferol-3,7-di-O-β-glucoside (Kaempferol 3,7-diglucoside) 是一种黄酮醇,对 α-淀粉酶 (α-amylase)、α-葡萄糖苷酶 (α-glucosidase) 和乙酰胆碱酯酶 (Acetylcholinesterase) 具有酶抑制作用。Kaempferol-3,7-di-O-β-glucoside 保护分化神经元细胞 SH-SY5Y 免受 Amyloid β 肽诱导的损伤。Kaempferol-3,7-di-O-β-glucoside 具有用于研究阿尔茨海默氏症的潜力。
- GC64556PTP1B-IN-15CAS: 765317-71-3
PTP1B-IN-15 是一种有效的选择性蛋白酪氨酸磷酸酶 1B (PTP1B) 抑制剂。PTP1B-IN-15具有研究II型糖尿病和肥胖症的潜力。
- GC64605MY33-3 hydrochlorideCAS: 2204280-42-0纯度: >99.00%
MY33-3 hydrochloride 是一种有效和选择性的蛋白酪氨酸磷酸酶 RPTPβ/ζ 抑制剂,IC50 值为 ~0.1 μM。MY33-3 hydrochloride 还抑制 PTP-1B (IC50 ~0.7 μM)。MY33-3 hydrochloride 可以减少乙醇消耗并缓解 Sevoflurane 引起的神经炎症和认知功能障碍。
- GC64607DazcapistatCAS: 2221010-42-8纯度: >98.00%
Dazcapistat 是一种有效的钙蛋白酶 (calpain) 抑制剂,对 calpain 1, calpain 2 和calpain 9 的 IC50 值为 <3 μM (详细信息请参见专利WO2018064119A1, compound 405)。
- GC64734BenzenesulphonamideCAS: 98-10-2纯度: >97.00%
Benzenesulfonamide (Benzenesulphonamide, Benzosulfonamide, Phenyl sulfonamide, Benzene sulfonamide) ia an inhibitor of carbonic anhydrases.
- GC65010Bortezomib-d8纯度: >98.00%
Bortezomib-d8 (PS-341-d8) 是 Bortezomib 的氘代物。Bortezomib (PS-341) 是一种可逆性和选择性的蛋白酶体 (proteasome) 抑制剂,通过靶向苏氨酸残基有效抑制 20S 蛋白酶体 (Ki=0.6 nM)。Bortezomib 破坏细胞周期、诱导细胞凋亡以及抑制核因子 NF-κB。Bortezomib 是第一种蛋白酶体抑制剂,具有抗癌活性。
- GC65097ARL67156 trisodium hydrate纯度: >99.00%
ARL67156 (FPL 67156) trisodium hydrate 是一种 ecto-ATPase 抑制剂。ARL67156 trisodium hydrate 是竞争性 NTPDase1 (CD39),NTPDase3 和 NPP1 抑制剂,Ki 分别为 11,18 和 12 μM。ARL67156 trisodium hydrate 可用于钙化性主动脉瓣疾病、哮喘等疾病的研究。
- GC65098ARL67156 triethylamine纯度: >99.50%
ARL67156 (FPL 67156) triethylamine 是一种 ecto-ATPase 抑制剂。ARL67156 triethylamine 是竞争性 NTPDase1 (CD39),NTPDase3 和 NPP1 抑制剂,Ki 分别为 11,18 和 12 μM。ARL67156 triethylamine 可用于钙化性主动脉瓣疾病、哮喘等疾病的研究。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC64031 | MP07-66 | 1938056-90-6 | - | |
MP07-66, a FTY720 analogue, is devoid of immunosuppressive effects and shows promising antitumor effects in chronic lymphocytic leukemia by disruption of the SET-PP2A complex leading to PP2A reactivation. | ||||
| GC64131 | TMX-4116 | 2766385-56-0 | >99.50% | |
TMX-4116 是酪蛋白激酶 1α (CK1α) 降解剂。TMX-4116 在 MOLT4、Jurkat 和 MM.1S 细胞中显示出对 CK1α 的降解偏好,DC50 小于 200 nM。TMX-4116 可用于多发性骨髓瘤的研究。 | ||||
| GC64161 | Calcium glycerophosphate | 27214-00-2 | >98.00% | |
Calcium glycerophosphate 是肠道碱性磷酸酶 F3 的抑制剂 (intestinal alkaline phosphatase F3)。Calcium glycerophosphate是全肠外营养溶液中钙和磷的来源。 | ||||
| GC64202 | Ganoderlactone D | 1801934-15-5 | >99.00% | |
Ganoderlactone D 对酵母中的α-葡萄糖苷酶有抑制活性,IC50 为 41.7 μM。 | ||||
| GC64213 | GSK3494245 | 2080410-41-7 | >98.00% | |
GSK3494245 (DDD01305143) 是一种有效的、具有口服活性的、选择性的可在夹在 β4 和 β5 亚基之间的位点结合寄生虫蛋白酶体 (proteasome) 的糜蛋白酶样活性抑制剂(对于 WT L.donovani蛋白酶体IC50=0.16μM)。GSK3494245 适度抑制人蛋白酶体的糜蛋白酶样活性 (IC50: 26S=13 µM;富集的 THP-1 提取物 IC50=40 µM)。GSK3494245 具有良好的生物安全特性。 | ||||
| GC64282 | LXE408 | 1799330-15-6 | - | |
LXE408 是一种口服有效的,非竞争性的,动素体选择性蛋白酶体 (proteasome) 抑制剂。LXE408 抑制 L. donovani 蛋白酶体 (IC50=0.04 μM) 和 L. donovani (EC50=0.04 μM)。LXE408 具有较弱的透过血脑屏障能力。LXE408 具有用于内脏利什曼病 (VL) 研究的潜力。 | ||||
| GC64338 | LYP-IN-1 | 1404436-51-6 | >98.50% | |
LYP-IN-1 是一种有效、选择性和特异性的 LYP 抑制剂,其 Ki,IC50 的值分别为 110 nM 和 0.259 μM。LYP-IN-1 对一些 PTPs 也有选择性,如 SHP1 (IC50=5 μM) 和 SHP2 (IC50=2.5 μM)。LYP-IN-1 在 T 细胞和肥大细胞中表现出高效的细胞活性。LYP-IN-1 可用于研究自身免疫性疾病。 | ||||
| GC64376 | GDC-1971 | 2377352-49-1 | - | |
GDC-1971 (compound 199) is a SHP2 inhibitor. | ||||
| GC64382 | SGC-CK2-1 | 2470424-39-4 | >99.00% | |
SGC-CK2-1 是一种高效、ATP 竞争性的 CK2 化学探针,对两种人 CK2 亚型 CK2α 和 CK2α' 具有选择性,IC50分别为 36 和 16 nM。SGC-CK2-1 可用于神经退行性疾病的研究。 | ||||
| GC64472 | 20S Proteasome-IN-1 | 858557-69-4 | >99.00% | |
20S Proteasome-IN-1 是一种 26S proteasome 抑制剂,详细信息请参考专利文献 WO2006128196A2 中的化合物 2。20S Proteasome-IN-1 具有用于癌症,免疫相关疾病,炎症,缺血性疾病,神经退行性疾病和其他疾病研究的潜力。 | ||||
| GC64507 | ML198 | 1380716-06-2 | >98.00% | |
ML198 is a novel activator of glucocerebrosidase (GCase) with an IC50 of 0.4 μM and does not inhibit the enzyme's action, but can facilitate its translocation to the lysosome. | ||||
| GC64519 | Kaempferol-3,7-di-O-β-glucoside | 25615-14-9 | - | |
Kaempferol-3,7-di-O-β-glucoside (Kaempferol 3,7-diglucoside) 是一种黄酮醇,对 α-淀粉酶 (α-amylase)、α-葡萄糖苷酶 (α-glucosidase) 和乙酰胆碱酯酶 (Acetylcholinesterase) 具有酶抑制作用。Kaempferol-3,7-di-O-β-glucoside 保护分化神经元细胞 SH-SY5Y 免受 Amyloid β 肽诱导的损伤。Kaempferol-3,7-di-O-β-glucoside 具有用于研究阿尔茨海默氏症的潜力。 | ||||
| GC64535 | (S,S)-TAPI-1 | 171235-71-5 | - | |
A TACE inhibitor | ||||
| GC64556 | PTP1B-IN-15 | 765317-71-3 | - | |
PTP1B-IN-15 是一种有效的选择性蛋白酪氨酸磷酸酶 1B (PTP1B) 抑制剂。PTP1B-IN-15具有研究II型糖尿病和肥胖症的潜力。 | ||||
| GC64605 | MY33-3 hydrochloride | 2204280-42-0 | >99.00% | |
MY33-3 hydrochloride 是一种有效和选择性的蛋白酪氨酸磷酸酶 RPTPβ/ζ 抑制剂,IC50 值为 ~0.1 μM。MY33-3 hydrochloride 还抑制 PTP-1B (IC50 ~0.7 μM)。MY33-3 hydrochloride 可以减少乙醇消耗并缓解 Sevoflurane 引起的神经炎症和认知功能障碍。 | ||||
| GC64607 | Dazcapistat | 2221010-42-8 | >98.00% | |
Dazcapistat 是一种有效的钙蛋白酶 (calpain) 抑制剂,对 calpain 1, calpain 2 和calpain 9 的 IC50 值为 <3 μM (详细信息请参见专利WO2018064119A1, compound 405)。 | ||||
| GC64638 | ALV1 | 2438124-79-7 | >95.00% | |
ALV1 是一种有效的 Ikaros 和 Helios 降解剂。ALV1 能显著降低 IKZF1-4、CK1α (酪蛋白激酶 1α,CSNK1A1) 和核糖体蛋白 RPL4 的蛋白丰度。ALV1 对和 IKZF1/2/3 表现出相似的降解活性。ALV1 诱导 Helios/CRBN 二聚反应。ALV1 在很大程度上促进了 IL-2 的分泌。 | ||||
| GC64734 | Benzenesulphonamide | 98-10-2 | >97.00% | |
Benzenesulfonamide (Benzenesulphonamide, Benzosulfonamide, Phenyl sulfonamide, Benzene sulfonamide) ia an inhibitor of carbonic anhydrases. | ||||
| GC64936 | TD52 dihydrochloride | - | >98.00% | |
A derivative of erlotinib | ||||
| GC64992 | YH-306 | 1373764-75-0 | >98.00% | |
YH-306 是一种抗肿瘤剂。YH-306 通过 FAK 通路抑制结直肠肿瘤的生长和转移。 YH-306 显着抑制结直肠癌细胞的迁移和侵袭。YH-306 有效抑制不受抑制的增殖并诱导细胞凋亡 (apoptosis)。YH-306 抑制 FAK、c-Src、桩蛋白和 PI3K、Rac1 的激活以及 MMP2 和 MMP9 的表达。YH-306 还抑制肌动蛋白相关蛋白 (Arp2/3) 复合物介导的肌动蛋白聚合。 | ||||
| GC65010 | Bortezomib-d8 | - | >98.00% | |
Bortezomib-d8 (PS-341-d8) 是 Bortezomib 的氘代物。Bortezomib (PS-341) 是一种可逆性和选择性的蛋白酶体 (proteasome) 抑制剂,通过靶向苏氨酸残基有效抑制 20S 蛋白酶体 (Ki=0.6 nM)。Bortezomib 破坏细胞周期、诱导细胞凋亡以及抑制核因子 NF-κB。Bortezomib 是第一种蛋白酶体抑制剂,具有抗癌活性。 | ||||
| GC65025 | BCI hydrochloride | 95130-23-7 | >99.00% | |
An inhibitor of DUSP6 and DUSP1 | ||||
| GC65097 | ARL67156 trisodium hydrate | - | >99.00% | |
ARL67156 (FPL 67156) trisodium hydrate 是一种 ecto-ATPase 抑制剂。ARL67156 trisodium hydrate 是竞争性 NTPDase1 (CD39),NTPDase3 和 NPP1 抑制剂,Ki 分别为 11,18 和 12 μM。ARL67156 trisodium hydrate 可用于钙化性主动脉瓣疾病、哮喘等疾病的研究。 | ||||
| GC65098 | ARL67156 triethylamine | - | >99.50% | |
ARL67156 (FPL 67156) triethylamine 是一种 ecto-ATPase 抑制剂。ARL67156 triethylamine 是竞争性 NTPDase1 (CD39),NTPDase3 和 NPP1 抑制剂,Ki 分别为 11,18 和 12 μM。ARL67156 triethylamine 可用于钙化性主动脉瓣疾病、哮喘等疾病的研究。 | ||||
